Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-5,068
Closed -$258K – 319
2020
Q2
$258K Buy
5,068
+1,976
+64% +$96K 0.05% 269
2020
Q1
$135K Buy
+3,092
New +$148K 0.03% 339
2017
Q1
– Sell
-4,970
Closed -$201K – 360
2016
Q4
$201K Buy
+4,970
New +$196K 0.03% 326
2016
Q3
– Sell
-21,492
Closed -$900K – 478
2016
Q2
$900K Buy
21,492
+4,822
+29% +$198K 0.07% 262
2016
Q1
$669K Buy
16,670
+1,175
+8% +$47.2K 0.05% 317
2015
Q4
$661K Sell
15,495
-2,039
-12% -$93.8K 0.06% 320
2015
Q3
$832K Buy
17,534
+11,818
+207% +$602K 0.07% 298
2015
Q2
$283K Buy
+5,716
New +$290K 0.04% 352

Other funds holding SNY

Arden Trust's SNY Position: Q3 2020 in Review

Arden Trust sold out of Sanofi (SNY) in Q3 2020, closing a stake of 5,068 shares — an estimated $258K sold.

Arden Trust first reported a position in SNY in Q2 2015 and held it in 8 quarters. The position peaked at $900K in Q2 2016. 573 funds tracked by Wall St. Rank hold SNY as of Q3 2020.

  • Arden Trust reported no remaining Sanofi position as of Q3 2020 after selling out during the quarter.
  • Arden Trust sold 5,068 Sanofi shares in Q3 2020, an estimated $258K.
  • Arden Trust first reported a position in Sanofi in Q2 2015 and held it in 8 quarters.
  • Arden Trust's Sanofi position peaked at $900K in Q2 2016.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q3 2020.

Based on Arden Trust's 13F filing for Q3 2020, filed 15 Oct 2020.